Bacteriophages for and were tested in experimental infections of mice to investigate their potential for the treatment of infections of man. As few as 10 particles of an acinetobacter phage protected mice against 5 LD50 (1 × 10) of a virulent strain of , and phage was demonstrated to have multiplied in the mice. A pseudomonas phage protected mice against 5 LD50 of a virulent strain of , with a PD50 of 1.2 × 10 particles. A staphylococcal phage failed to protect mice infected with a strain of . These studies support the view that bacteriophages could be useful in the treatment of human infections caused by antibiotic-resistant strains of bacteria.


Article metrics loading...

Loading full text...

Full text loading...


Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error